Natural Product Details
Structure:
| Product ID: | N00638 |
| Product Name: | ( E) - Z - Hexenal |
| CAS No: | 85761702 |
| Molecular Formula: | C6H10O |
| SMILES: | CCC/C=C/C=O |
| InChiKey: | MBDOYVRWFFCFHM-SNAWJCMRSA-N |
| Category: | Fatty acids |
| Biological Source: |

| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| D057 | Camu camu | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D081 | Citrus unshiu | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D135 | Fenugreek | Biological extract | -- | -- | -- | Under clinical trials | Details |
| D190 | Japanese apricot extract | Biological extract | -- | -- | -- | Failed in clinical trials | Details |
| D228 | Misatol GL | Biological extract | -- | -- | -- | Failed in clinical trials | Details |
| D249 | Ocimum Basilicum | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D315 | Saberry capsules | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D331 | Shizazi thyme | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D368 | Thriphala choorna | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D402 | A mixture of Anethum graveolens, Citrus bigardia, Cynara scolymus, Portulaca oleracea, and Silybum marianum | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D518 | ALT-801 | Biological drug | DB15386 | -- | -- | Under clinical trials | Details |
| D523 | Capparis Spinosa Fruit pickle | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D543 | Plantago Psyllium and Ocimum Basilicum seeds | Herbal medicine | -- | -- | -- | Under clinical trials | Details |
| D560 | Grape seed polyphenols | Biological extract | -- | -- | -- | Under clinical trials | Details |
| D564 | Rice Bran Nutritional Supplement | Biological extract | -- | -- | -- | Under clinical trials | Details |
| D566 | Zataria multiflora Boiss. | Herbal medicine | -- | -- | -- | Under clinical trials | Details |